HECHT LATHAM SPENCER & ASSOCIATES, INC., FORMERLY KNOWN AS HECHT SPENCER & ASSOC for EMERGENT BIOSOLUTIONS
What was lobbied
4 issue areas, each in the filer's own words, with who lobbied on it and where.
Disaster Planning/Emergencies DIS
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Budget/Appropriations BUD
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Homeland Security HOM
H.R. 133 - Consolidated Appropriations Act, 2021 - Division H, Title II, Department of Health and Human Services - provisions and funding for development, acquisition and stockpiling of medical countermeasures (MCM) and Division M, Coronavirus Response Supplemental Appropriations Act, 2021 - funding for COVID-19 vaccines/therapeutics and distribution; H.R. 6395 and S. 4049 - National Defense Authorization Act for Fiscal Year 2021 - provisions related to biological and chemical defense and access to Naloxone opioid reversal in military health system; H.R. 6800 - Health and Economic Recovery Omnibus Emergency Solutions Act (HEROES Act) - provisions related to the development, acquisition and stockpiling of medical countermeasures for the U.S. government; H.R. 8406 - The HEROES Act - Supplemental Stimulus Appropriations - provisions related to development, acquisition, and stockpiling of medical countermeasures for the U.S. government; Initiatives and products to combat the opioid health crisis, including naloxone access and prescribing guidelines; H.R. 2466 - State Opioid Response Grant Authorization Act - entire bill; S. 4058 - Emergency Support for Substance Use Disorders Act - emergency grants for states and community organizations serving individuals with substance use disorder; H.R. 7574 - Strengthening America's Strategic National Stockpile Act of 2020 - entire bill.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Taxation/Internal Revenue Code TAX
IRS processing of corporate name change.
| Lobbyist | Covered position, as disclosed |
|---|---|
| TIMOTHY P HECHT | — |
| THOMAS PAUL LATHAM | — |
| FRANKLIN C PHIFER | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.